Cullinan Therapeutics (CGEM) Shares Outstanding (2020 - 2023)
Historic Shares Outstanding for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $42.8 million.
- Cullinan Therapeutics' Shares Outstanding fell 651.99% to $42.8 million in Q3 2023 from the same period last year, while for Sep 2023 it was $42.8 million, marking a year-over-year decrease of 651.99%. This contributed to the annual value of $45.8 million for FY2022, which is 339.64% up from last year.
- Cullinan Therapeutics' Shares Outstanding amounted to $42.8 million in Q3 2023, which was down 651.99% from $42.7 million recorded in Q2 2023.
- Cullinan Therapeutics' Shares Outstanding's 5-year high stood at $45.8 million during Q4 2022, with a 5-year trough of $20.0 million in Q1 2020.
- In the last 4 years, Cullinan Therapeutics' Shares Outstanding had a median value of $43.5 million in 2021 and averaged $38.1 million.
- Per our database at Business Quant, Cullinan Therapeutics' Shares Outstanding soared by 11790.76% in 2021 and then crashed by 1190.42% in 2023.
- Over the past 4 years, Cullinan Therapeutics' Shares Outstanding (Quarter) stood at $29.8 million in 2020, then surged by 48.48% to $44.3 million in 2021, then rose by 3.4% to $45.8 million in 2022, then fell by 6.63% to $42.8 million in 2023.
- Its Shares Outstanding stands at $42.8 million for Q3 2023, versus $42.7 million for Q2 2023 and $39.3 million for Q1 2023.